Adverse events with HeartMate-3 Left ventricular assist device: Results from the Manufacturer and User Facility Device Experience (MAUDE) database

Adverse events with HeartMate-3 Left ventricular assist device: Results from the Manufacturer and User Facility Device Experience (MAUDE) database

None.

Bibliographic Details
Main Authors:	Joseph N. Heaton, Sohrab Singh, Matthew Li, Saraschandra Vallabhajosyula
Format:	Article
Language:	English
Published:	Elsevier 2021-11-01
Series:	Indian Heart Journal
Subjects:	Left ventricular assist device Post-marketing surveillance HeartMate-3 Heart failure Complications
Online Access:	http://www.sciencedirect.com/science/article/pii/S0019483221002273

Similar Items

Totally percutaneous endovascular repair of HeartMate 3 ventricular assistive device outflow graft pseudoaneurysm
by: Mark D. Balceniuk, MD, MPH, et al.
Published: (2020-12-01)

Electrostatic Discharge Causing Pump Shutdown in HeartMate 3
by: Emil Najjar, MD, PhD, et al.
Published: (2021-03-01)

MediGuide-assisted atrial flutter ablation in a patient with a HeartMate II left ventricular assist device
by: Hien Kiem Nguyen Thanh, MD, et al.
Published: (2015-09-01)

Eight months of HeartMate II device support without drug therapy
by: Kewal Krishan, et al.
Published: (2017-01-01)

Ischemic cardiomyopathy is an independent predictor of mortality in patients presenting for Heart Mate II left ventricular assist device implantation
by: Sanjay Kumar, et al.
Published: (2017-01-01)

Surgical Outcomes of Centrifugal Continuous-Flow Implantable Left Ventricular Assist Devices: Heartmate 3 versus Heartware Ventricular Assist Device
by: Kinam Shin, et al.
Published: (2024-03-01)

First Pediatric HeartMate 3 Ventricular Assist Device Implantation in Romania – a Case Report
by: Muntean Iolanda, et al.
Published: (2024-02-01)

Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States
by: Teruhiko Imamura, et al.
Published: (2020-03-01)

Left Ventricular Assist Device Implantation in a Thrombosed Apical Aneurysm
by: Daniele Masarone, et al.
Published: (2021-07-01)

HeartMate 3 biventricular support exceeding 4.5 years
by: Hrvoje Gasparovic, et al.
Published: (2023-06-01)

Third‐generation continuous‐flow left ventricular assist devices: a comparative outcome analysis by device type
by: Maks Mihalj, et al.
Published: (2022-10-01)

Use of Intracorporeal Durable LVAD Support in Children Using HVAD or HeartMate 3—A EUROMACS Analysis
by: Martin Schweiger, et al.
Published: (2023-08-01)

Comparison of the Hemocompatibility of an Axial and a Centrifugal Left Ventricular Assist Device in an In Vitro Test Circuit
by: Patrick Borchers, et al.
Published: (2022-06-01)

Biventricular assist devices and total artificial heart: Strategies and outcomes
by: Taiyo Kuroda, et al.
Published: (2023-01-01)

Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes
by: Sachin P. Shah, et al.
Published: (2016-04-01)

Commentary: Cost-Effectiveness of Left Ventricular Assist Devices as Destination Therapy in the United Kingdom
by: Priyansh Faldu, et al.
Published: (2022-07-01)

Insights Into the Low Rate of In-Pump Thrombosis With the HeartMate 3: Does the Artificial Pulse Improve Washout?
by: Peng Fang, et al.
Published: (2022-03-01)

Left ventricular assist device exchange from HeartMate II to HeartMate 3 in an Asian patient—a case report and literature review
by: Hsiao-Huang Chang, et al.
Published: (2023-03-01)

Monitoring pulmonary pressures during long‐term continuous‐flow left ventricular assist device and fixed pulmonary hypertension: redefining alleged pathophysiological mechanisms?
by: Chantal C. De Bakker, et al.
Published: (2020-04-01)

Chest radiographs of cardiac devices (Part 2): Ventricular assist devices
by: Rishi P. Mathew, et al.
Published: (2019-07-01)

HeartMate 3 Implantation via Only Left Thoracotomy: A Case Report
by: Mi Young Jang, et al.
Published: (2023-05-01)

Role of Genetic Polymorphisms in the Development of Complications in Patients with Implanted Left Ventricular Assist Devices: HeartWare, HeartMate II, and HeartMate 3
by: Madina R. Zhalbinova, et al.
Published: (2023-11-01)

Impact of diastolic pulmonary gradient and pulmonary vascular remodeling on survival after left ventricular assist device implantation and heart transplantation
by: Mohamed Laimoud, et al.
Published: (2023-12-01)

Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry
by: Alessandra Francica, et al.
Published: (2023-09-01)

The endogenous thrombin potential in patients with left ventricular assist device or heart transplant
by: Axel Schlagenhauf, et al.
Published: (2023-04-01)

Corrigendum: Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry
by: Alessandra Francica, et al.
Published: (2023-10-01)

Pericardial release for early LVAD malalignment a less invasive approach
by: Eric I. Jeng, et al.
Published: (2021-03-01)

Application of mathematical modeling to quantify ventricular contribution following durable left ventricular assist device support
by: Viswajith S. Vasudevan, et al.
Published: (2022-09-01)

The Impact of Intrapericardial versus Intrapleural HeartMate 3 Pump Placement on Clinical Outcomes
by: Michael Salna, et al.
Published: (2022-06-01)

Computational Evaluation of Cardiac Function in Children Supported with Heartware VAD, HeartMate 2 and HeartMate 3 Left Ventricular Assist Devices
by: Koray K. Şafak, et al.
Published: (2022-02-01)

Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
by: Lieke Numan, et al.
Published: (2023-06-01)

Gastrointestinal bleeding on continuous‐flow left ventricular assist device therapy
by: Yoav Hammer, et al.
Published: (2023-08-01)

Influence of Atrial Fibrillation on Functional Tricuspid Regurgitation in Patients With HeartMate 3
by: Hideyuki Hayashi, et al.
Published: (2021-02-01)

The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support
by: Cecilia Berardi, et al.
Published: (2022-04-01)

Management of incessant ventricular arrhythmias in a patient with left ventricular assist device: a case report
by: Chen Chen, et al.
Published: (2024-04-01)

Ablation of ventricular tachycardia in a patient with a left ventricular assist device
by: Evrim Şimşek, et al.
Published: (2020-01-01)

Identifying Temporal Relationships Between In‐Hospital Adverse Events After Implantation of Durable Left Ventricular Assist Devices
by: Arman Kilic, et al.
Published: (2020-04-01)

The good, the bad, the ugly: Optimal left ventricular assist device duration in bridge to transplantationCentral Message
by: Matthew L. Goodwin, MD, et al.
Published: (2021-12-01)

Perioperative management of left ventricular assist devices
by: O P Sanjay
Published: (2016-01-01)

Successful surgical treatment of terminal heart failure in an adolescent - left ventricular assist device implantation and subsequent heart transplantation
by: Putnik Svetozar, et al.
Published: (2019-01-01)